converting between glp 1 agonists GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Impact of GLP- 1 Receptor
Description
Liraglutide 3.0 mg (Saxenda
Lin H-T, Tsai Y-F, Liao P-L, Wei JCC
Novo Nordisk A/S: CagriSema Demonstrated Superior HbA1c Reduction of 1.91 Percent Points and Weight Loss of 14.2 Percent in Adults with Type 2 Diabetes in the REIMAGINE 2 Trial
October 24, 2023
28 A crucial tool to lower costs is swift generic competition, and addressing the patent and exclusivity landscape for drug-device combinations such as GLP-1 receptor agonists is key for facilitating such competition
